These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12877062)

  • 21. Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.
    Hall J; Naranjo CA; Sproule BA; Herrmann N
    J Clin Psychopharmacol; 2003 Aug; 23(4):349-57. PubMed ID: 12920410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.
    Loiseau P
    Drug Saf; 1998 Dec; 19(6):495-510. PubMed ID: 9880092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol-drug interactions.
    FDA Drug Bull; 1979 Jun; 9(2):10-2. PubMed ID: 38165
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interactions with peroral anticoagulants (AC)].
    Christensen HR
    Ugeskr Laeger; 2000 Feb; 162(9):1253. PubMed ID: 10741239
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
    Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
    Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiretroviral HIV therapy and hormonal contraceptives].
    Thorsteinsson K; Lebech AM; Dalhoff KP; Wilken-Jensen C; Katzenstein TL
    Ugeskr Laeger; 2018 Jul; 180(30):. PubMed ID: 30037382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
    Tomalik-Scharte D; Lazar A; Fuhr U; Kirchheiner J
    Pharmacogenomics J; 2008 Feb; 8(1):4-15. PubMed ID: 17549068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics in patients with burns.
    Jaehde U; Sörgel F
    Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Benzodiazepine interactions with other drugs].
    Fossati C
    Clin Ter; 1987 Aug; 122(3):209-12. PubMed ID: 2904318
    [No Abstract]   [Full Text] [Related]  

  • 30. Ethopharmacology of social conflict and communication: anxiolytics, antidepressants, antipsychotics, and analgesics. Second international meeting of the European Behavioural Pharmacology Society. Athens, Greece, 31 August-3 September 1988. Proceedings.
    Psychopharmacology (Berl); 1989; 97(2):141-283. PubMed ID: 2567020
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytochrome P-450-catalyzed xenobiotic metabolism--initial results with an in vitro test system].
    Skölziger R; Wagner G; Wohlrab W; Beyer C; Damrau J
    Z Gesamte Hyg; 1987 Nov; 33(11):598-600. PubMed ID: 3439239
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
    El-Ibiary SY; Cocohoba JM
    Eur J Contracept Reprod Health Care; 2008 Jun; 13(2):123-32. PubMed ID: 18465473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine and psychiatric medication interactions: a review.
    Broderick PJ; Benjamin AB; Dennis LW
    J Okla State Med Assoc; 2005 Aug; 98(8):380-4. PubMed ID: 16206866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
    Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
    Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk and predictability of drug interactions in the elderly.
    Levy RH; Collins C
    Int Rev Neurobiol; 2007; 81():235-51. PubMed ID: 17433928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin drug interactions.
    Smith V; Strum M; Smith E
    J Ark Med Soc; 2004 Dec; 101(6):175-6. PubMed ID: 15619952
    [No Abstract]   [Full Text] [Related]  

  • 37. Up and down regulation: clinical significance of nervous system receptor-drug interactions.
    Kurlan R; Shoulson I
    Clin Neuropharmacol; 1982 Dec; 5(4):345-50. PubMed ID: 6130837
    [No Abstract]   [Full Text] [Related]  

  • 38. Dosing of medications in morbidly obese patients in the intensive care unit setting.
    Erstad BL
    Intensive Care Med; 2004 Jan; 30(1):18-32. PubMed ID: 14625670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting in vivo drug interactions from in vitro drug discovery data.
    Wienkers LC; Heath TG
    Nat Rev Drug Discov; 2005 Oct; 4(10):825-33. PubMed ID: 16224454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of clinically important drug interactions with carbamazepine. Part I.
    Ketter TA; Post RM; Worthington K
    J Clin Psychopharmacol; 1991 Jun; 11(3):198-203. PubMed ID: 2066459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.